ACTIVITY OF TRIAZOLES AND ECHINOCANDINS AGAINST CANDIDA BLOODSTREAM ISOLATES AT PHRAMONGKUTKLAO HOSPITAL, THAILAND

  • Sudaluck Thunyaharn Faculty of Medical Technology, Nakhon Ratchasima College, Nakhon Ratchasima, Thailand
  • Wichai Santimaleeworagun Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakorn Pathom, Thailand
  • Chananan Khoprasert Department of Microbiology, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Piyanate Kesakomol Department of Microbiology, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Montalee Theeraapisakkun Department of Biochemistry, Phramongkutklao College of Medicine, Bangkok, Thailand
  • Unchalee Visawapoka Department of Biochemistry, Phramongkutklao College of Medicine, Bangkok, Thailand
Keywords: Triazoles, Echinocandins, Candida spp., bloodstream infection

Abstract

Background: Candidemia is a major cause of morbidity and mortality which can be treated using antifungal agents, triazoles and echinocandins.

Objectives: We aimed to determine Candida species and their sensitivities to triazoles (fluconazole, itraconazole, voriconazole, and posaconazole) and echinocandins (caspofungin, micafungin, and anidulafungin) among patients with candidiasis to guide future treatment of patients with candidemia or invasive candidiasis.

Methods: All firstly isolated Candida spp. from patients admitted at Phramongkutklao Hospital, Bangkok, Thailand from January 2012 to December 2013 were included in this study. The antifungal susceptibility testing of Candida spp. isolates was assessed based on micro-dilution method.

Results: During the 24-month study period, a total of 66 Candida isolates from 66 patients were identified. Of the 66 isolates, 35 (53%) were C. albicans, 18 (27.3%) were C. tropicalis, 10 (15.2%) were C. glabrata and 3 (4.5%) were C. parapsilosis. Fluconazole resistant Candida isolates were found in C. glabrata (100%), C. albicans (14.3%), C. tropicalis (22.2%) and C. parapsilosis (66.7%). Most Candida spp. isolates were mainly susceptible to echinocandins (>90%). Notably, 10%-20% of C. glabrata isolates showed resistance to echinocandins.

Conclusion: Fluconazole, an empirical therapy, has been cautiously used due to resistant non-albicans Candida species especially, C. glabrata, C. tropicalis and C. parapsilosis. However, the emerging echinocandins resistant C. glabrata isolates need to be closely monitored.

Downloads

Download data is not yet available.

References

Enoch DA, Yang H, Aliyu SH, Micallef C. The changing epidemiology of invasive fungal infections. Methods Mol Biol 2017; 1508: 17-65.

Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild M, Bohlius J, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect 2019; 10: 1200-12.

Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect 2014; 20 (Suppl 6): 5-10.

Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 2013; 56: 1724-32.

Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002. J Med Assoc Thai 2004; 87: 92-9.

Tan TY, Hsu LY, Alejandria MM, Chaiwarith R, Chinniah T, Chayakulkeeree M, et al. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol 2016; 54: 471-7.

Jutiamornlerd N, Chusri S, Siripaitoon P. Epidemiology of candidemia in Songklanagarind Hospital. J Med Assoc Thai 2011; 94: 927-32.

Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 2015; 21: 946-53.

Chaiwarith R, Ounbang P, Khamwan C, Nuntachit N, Sirisanthana T, Supparatpinyo K. Epidemiology of adult candidemia at Chiang Mai University Hospital. Southeast Asian J Trop Med Public Health 2011; 42: 1505-14.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62: e1-50.

Ngamchokwathana C, Chongtrakool P, Waesamaae A, Chayakulkeeree M. Risk factors and outcomes of non-albicans Candida bloodstream infection in patients with candidemia at Siriraj Hospital-Thailand’s largest national tertiary referral hospital. J Fungi (Basel) 2021; 7: 269.

Fernandez-Ruiz M, Aguado JM, Almirante B, Lora-Pablos D, Padilla B, Puig-Asensio M, et al. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis. Clin Infect Dis 2014; 58: 1413-21.

Minimum Inhibitory Concentration (MIC)
Published
2021-11-09
How to Cite
1.
Thunyaharn S, Santimaleeworagun W, Khoprasert C, Kesakomol P, Theeraapisakkun M, Visawapoka U. ACTIVITY OF TRIAZOLES AND ECHINOCANDINS AGAINST CANDIDA BLOODSTREAM ISOLATES AT PHRAMONGKUTKLAO HOSPITAL, THAILAND. J Southeast Asian Med Res [Internet]. 2021Nov.9 [cited 2021Dec.9];5(2):84-0. Available from: https://www.jseamed.org/index.php/jseamed/article/view/96
Section
Original Articles

Most read articles by the same author(s)